Autonomix
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21 Waterway Ave Ste 300, The Woodlands, ...Phone Number
(713) 588-6150Website
www.autonomix.comRevenue
-Stock Symbol
AMIXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
2
1
1
1
1
About Autonomix
Autonomix Medical, Inc. is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the peripheral nervous system are diagnosed and treated. The Companys first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with up to 3,000 times greater sensitivity than currently available technologies. The company believes this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body. The company is initially developing the company's technology for pancreatic cancer pain and pancreatitis pain, conditions that can cause debilitating pain and need an effective solution. However, the company's technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across aRead more
Autonomix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Autonomix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Autonomix launches new products
Funding: Get notified immidiatlly once Autonomix has new funding data
Autonomix, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Autonomix recently announced quarterly report
Check out if Autonomix is spiking on competitors!
Check if Autonomix has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Autonomix
Website visits: Recent activity has been detected on your website
Click to see if Autonomix had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Autonomix
Compare insights from companies similar to Autonomix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Autonomix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Autonomix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Autonomix.
Autonomix financials insights
Gather financial insights about Autonomix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Stock Offering
$11.1M
Autonomix Tech Stack
A closer look at the technologies used by Autonomix
See more technologies
Most Recent Scoops
Project
Intellectual Property, Legal Affairs, Healthcare Technology
Project
Product Development, Research & Development, Medical Research, Clinical Operations, Healthcare Technology
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Software, Healthcare Technology, Industry Software
Project
Intellectual Property, Legal Affairs, Healthcare Technology
Earnings
Earnings, Finance
Autonomix News & Media
Autonomix Announces Reverse Stock Split
THE WOODLANDS, TX, June 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-21 reverse stock split of its common stock. The reverse stock split will take effect at 12:01 am (EasternAutonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine
Dr. Toufic Kachaamy Discusses Visceral Cancer Pain Treatment Differentiation, Pancreatic Cancer Feasibility Data, and Peripheral Nervous System Platform PotentialAutonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation
Technology unlocks minimally invasive transvascular access to nerve targets and tissues through and beyond the lumen wall
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Autonomix
Sign Up For FreeTo access detailed company insights
Autonomix Medical, Inc. is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the peripheral nervous system are diagnosed and treated. The Companys first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural si... Read More
